Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective.

Zhang, Yongsheng; Liang, Xinjie; Bao, Xuefei; Xiao, Wei; Chen, Guoliang

Zhang, Yongsheng; Liang, Xinjie; Bao, Xuefei; Xiao, Wei; Chen, Guoliang.

Affiliation

Zhang Y; Key Laboratory of Structure-Based Drugs Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, China.
Liang X; Key Laboratory of Structure-Based Drugs Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, China.
Bao X; Jiangsu Kanion Pharmaceutical Co.,Ltd., Lianyungang, China; Key Laboratory of Structure-Based Drugs Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, China. Electronic address: bxf551@163.com.
Xiao W; Jiangsu Kanion Pharmaceutical Co.,Ltd., Lianyungang, China. Electronic address: xw_kanion@163.com.
Chen G; Key Laboratory of Structure-Based Drugs Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, China. Electronic address: spucgl@163.com.

Eur J Med Chem ; 235: 114291, 2022 May 05.

Article de En | MEDLINE | ID: mdl-35307617

Sujet(s)
Mots clés

Anti-inflammatory; Inhibitors; Molecular docking; Toll-like receptor 4

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antigène lymphocytaire-96 / Récepteur de type Toll-4 Type d'étude: Observational_studies / Risk_factors_studies Limites: Animals Langue: En Journal: Eur J Med Chem Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: France

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google